p38 MAPK contributes to CD54 expression and the enhancement of phagocytic activity during macrophage development

Cellular Immunology

Volumn 256, Issue 1-2, 2009, Pages 6-11

  Cui, Jian ^a   Zhu, Ning ^b   Wang, Qingyang ^a   Yu, Ming ^a   Feng, Jiannan ^a   Li, Yan ^a   Zhang, Jiyan ^a   Shen, Beifen ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b HENAN UNIVERSITY   (China)

Author keywords

CD54; Development; Macrophage; p38; Phagocytosis

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 [4 (4 FLUOROPHENYL) 5 (2 METHOXY 4 PYRIMIDINYL) 1 IMIDAZOLYL]CYCLOHEXANOL; CD14 ANTIGEN; COLONY STIMULATING FACTOR 1; INTERCELLULAR ADHESION MOLECULE 1; ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CELL MATURATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD11B; ANTIGENS, CD14; ANTIGENS, DIFFERENTIATION; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; ENZYME ACTIVATION; FEMALE; IMIDAZOLES; INTERCELLULAR ADHESION MOLECULE-1; MACROPHAGE ACTIVATION; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 11; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHAGOCYTOSIS; PROTEIN KINASE INHIBITORS; PYRIDINES; PYRIMIDINES;

MURINAE; MUS;

EID: 61849088455     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2008.12.003     Document Type: Article

References (28)

1. Ashwell J.D. The many paths to p38 mitogen-activated protein kinase activation in the immune system. Nat. Rev. Immunol. 6 (2006) 532-540
2. Kumar S., Boehm J., and Lee J.C. P38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat. Rev. Drug Discov. 2 (2003) 717-726
3. Zhang J., Shen B., and Lin A. Novel strategies for inhibition of the p38 MAPK pathway. Trends Pharmacol. Sci. 28 (2007) 286-295
4. Bhattacharyya S., Brown D.E., Brewer J.A., Vogt S.K., and Muglia L.J. Macrophage glucocorticoid receptors regulate Toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase. Blood 109 (2007) 4313-4319
5. Beardmore V.A., Hinton H.J., Eftychi C., Apostolaki M., Armaka M., Darragh J., McIlrath J., Carr J.M., Armit L.J., Clacher C., Malone L., Kollias G., and Arthur J.S. Generation and characterization of p38beta (MAPK11) gene-targeted mice. Mol. Cell. Biol. 25 (2005) 10454-10464
6. Sabio G., Arthur J.S., Kuma Y., Peggie M., Carr J., Murray-Tait V., Centeno F., Goedert M., Morrice N.A., and Cuenda A. P38gamma regulates the localisation of SAP97 in the cytoskeleton by modulating its interaction with GKAP. EMBO J. 24 (2005) 1134-1145
7. Hui L., Bakiri L., Mairhorfer A., Schweifer N., Haslinger C., Kenner L., Komnenovic V., Scheuch H., Beug H., and Wagner E.F. p38alpha suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway. Nat. Genet. 39 (2007) 741-749
8. Ventura J.J., Tenbaum S., Perdiguero E., Huth M., Guerra C., Barbacid M., Pasparakis M., and Nebreda A.R. p38alpha MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation. Nat. Genet. 39 (2007) 750-758
9. Cuenda A., Rouse J., Doza Y.N., Meier R., Cohen P., Gallagher T.F., Young P.R., and Lee J.C. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364 (1995) 229-233
10. Lee J.C., Laydon J.T., McDonnell P.C., Gallagher T.F., Kumar S., Green D., McNulty D., Blumenthal M.J., Heys J.R., and Landvatter S.W. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372 (1994) 739-746
11. Lin H., Chen C., and Chen B.D. Resistance of bone marrow-derived macrophages to apoptosis is associated with the expression of X-linked inhibitor of apoptosis protein in primary cultures of bone marrow cells. Biochem. J. 353 (2001) 299-306
12. Zhang J., Shen B., Li Y., and Sun Y. STAT3 exerts two-way regulation in the biological effects of IL-6 in M1 leukemia cells. Leukoc. Res. 25 (2001) 463-472
13. Zhang J., Bui T.N., Xiang J., and Lin A. Cyclic AMP inhibits p38 activation via CREB-induced dynein light chain. Mol. Cell. Biol. 26 (2006) 1223-1234
14. Zarubin T., and Han J. Activation and signaling of the p38 MAP kinase pathway. Cell Res. 15 (2005) 11-18
15. Raman M., Chen W., and Cobb M.H. Differential regulation and properties of MAPKs. Oncogene 26 (2007) 3100-3112
16. Zhu N., Cui J., Qiao C., Li Y., Ma Y., Zhang J., and Shen B. CAMP modulates macrophage development by suppressing M-CSF-induced MAPKs activation. Cell Mol. Immunol. 5 (2008) 153-157
17. Himes S.R., Sester D.P., Ravasi T., Cronau S.L., Sasmono T., and Hume D.A. The JNK are important for development and survival of macrophages. J. Immunol. 176 (2006) 2219-2228
18. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y., Bhagwat S.S., Manning A.M., and Anderson D.W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA 98 (2001) 13681-13686
19. Morris L., Graham C.F., and Gordon S. Macrophages in haemopoietic and other tissues of the developing mouse detected by the monoclonal antibody F4/80. Development 112 (1991) 517-526
20. Duits A.J., Dimjati W., van de Winkel J.G., and Capel P.J. Synergism of interleukin 6 and 1 alpha, 25-dihydroxyvitamin D3 in induction of myeloid differentiation of human leukemic cell lines. J. Leukoc. Biol. 51 (1992) 237-243
21. Obata S., Okada S., Ohkubo Y., Murasawa M., Hatano M., Sekiya S., and Tokuhisa T. Overexpression of the c-fos gene perturbs functional maturation of M1 cells into macrophages. Mol. Immunol. 39 (2003) 585-594
22. Rausch O., and Marshall C.J. Cooperation of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways during granulocyte colony-stimulating factor-induced hemopoietic cell proliferation. J. Biol. Chem. 274 (1999) 4096-4105
23. Wang J.M., Lai M.Z., and Yang-Yen H.F. Interleukin-3 stimulation of mcl-1 gene transcription involves activation of the PU.1 transcription factor through a p38 mitogen-activated protein kinase-dependent pathway. Mol. Cell. Biol. 23 (2003) 1896-1909
24. Huang Z., Li S., and Korngold R. Immunoglobulin superfamily proteins: structure, mechanisms, and drug discovery. Biopolymers 43 (1997) 367-382
25. Iotsova V., Caamano J., Loy J., Yang Y., Lewin A., and Bravo R. Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat. Med. 3 (1997) 1285-1289
26. Liu S.F., Ye X., and Malik A.B. Inhibition of NF-kappaB activation by pyrrolidine dithiocarbamate prevents In vivo expression of proinflammatory genes. Circulation 100 (1999) 1330-1337
27. Madrid L.V., Mayo M.W., Reuther J.Y., and Baldwin Jr. A.S. Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J. Biol. Chem. 276 (2001) 18934-18940
28. Sawka-Verhelle D., Escoubet-Lozach L., Fong A.L., Hester K.D., Herzig S., Lebrun P., and Glass C.K. PE-1/METS, an antiproliferative Ets repressor factor, is induced by CREB-1/CREM-1 during macrophage differentiation. J. Biol. Chem. 279 (2004) 17772-17784